151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset

    Wolfgang Weger, Barbara Gruber, Gudrun Ratzinger, Leo Richter, Paul-Gunther Sator

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →